Skip to content

Evaluation of the use of Telemedicine in Pediatric Intensive Care Units: Randomized Controlled Trial.

Evaluation of the Impact of Telemedicine Use on Clinical Care Indicators in Pediatric Intensive Care Units: Cluster Randomized Controlled Trial.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-7xj4wyp
Enrollment
Unknown
Registered
2022-03-22
Start date
2022-05-02
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Unspecified bacterial pneumonia

Interventions

880 patients in the experimental group telemedicine intervention (Tele-critical care and continuing education activities). The tele-Critical Care consisting of establishing a diagnosis, guiding the th
H02.403.840

Sponsors

Programa de Apoio ao Desenvolvimento Institucional do Sistema Único de Saúde
Lead Sponsor
Programa de Apoio ao Desenvolvimento Institucional do Sistema Único de Saúde
Collaborator

Eligibility

Age
29 Days to 18 Years

Inclusion criteria

Inclusion criteria: All children admitted in the pediatric Intensive Care Unit (ICU) aged bigger or equal 29 days and smaller 18 years, with a length of stay greater than 8 hours, and in case of death, greater than 24 hours

Exclusion criteria

Exclusion criteria: Patients with incomplete medical records or with incomplete data in the institution's database; patients whose guardians did not accept to participate in the study and/or who did not sign the Informed Consent Form (FICF) and term of use of image

Design outcomes

Primary

MeasureTime frame
Our primary outcome will be the length of stay, which will be presented in days and calculated by subtracting the date of discharge from the date of admission to the Pediatric Intensive Care Unit

Secondary

MeasureTime frame
As secondary outcomes, we will evaluate the mortality rate, which will be estimated by dividing the number of deaths in each unit by the number of patients discharged during the telemedicine follow-up period. In addition, we will evaluate days free from mechanical ventilation, as well as the time of use of vasoactive drugs, time of use of broad-spectrum antibiotic and time of use of sedation and analgesia

Countries

Brazil

Contacts

Public ContactFelipe Cabral

Hospital Moinhos de Vento

felipe.cabral@hmv.org.br+55 (51) 99771-8676

Outcome results

None listed

Source: REBEC (via WHO ICTRP)